Almirall buys derma firm Aqua for $305m+
This article was originally published in Scrip
Spanish pharma group Almirall has agreed to acquire Aqua Pharmaceuticals, a privately owned prescription dermatology company based in the US. It will pay $305m up front, and up to $75m in additional payments contingent on certain regulatory and commercial milestones being met during 2014 and 2015. It will also pay $22.6m up front related to amortization of certain long-term tax assets.